Beta blockers remain a cornerstone of cardiovascular treatment, and the metoprolol vs atenolol comparison comes up frequently because these two medications are among the most prescribed in their class. Both are selective beta-1 blockers that primarily target the heart, slowing heart rate and reducing blood pressure. However, they differ in important ways, including how the body processes them, their evidence base for specific conditions, and their side effect profiles. These differences can significantly affect treatment outcomes and daily quality of life.
According to the CDC, heart disease is the leading cause of death in the United States, and beta blockers are prescribed to tens of millions of Americans. Whether you are starting a new prescription or considering a switch, understanding how these two medications compare will help you have a more productive conversation with your cardiologist. Our medical conditions guide covers many of the conditions these medications treat.
How Metoprolol and Atenolol Work
Both metoprolol and atenolol are cardioselective (beta-1 selective) blockers, meaning they preferentially block beta-1 receptors found predominantly in heart tissue. By blocking these receptors, they reduce heart rate, decrease the force of heart contractions, and lower blood pressure. They also reduce the heart’s demand for oxygen, which is why they are valuable in managing angina and post-heart attack care.
Cardioselectivity is important because it means these medications are less likely to affect beta-2 receptors in the lungs and blood vessels compared to non-selective beta blockers like propranolol. This makes them safer options for patients with mild asthma or COPD, though caution is still warranted. The National Library of Medicine notes that metoprolol’s selectivity decreases at higher doses, which is true for both medications.
Key Differences at a Glance
| Feature | Metoprolol | Atenolol |
|---|---|---|
| Brand Names | Lopressor (tartrate), Toprol-XL (succinate) | Tenormin |
| Formulations | Immediate-release and extended-release | Immediate-release only |
| Lipophilicity | Lipophilic (fat-soluble) | Hydrophilic (water-soluble) |
| Crosses Blood-Brain Barrier | Yes | Minimal |
| Half-Life | 3-7 hours (tartrate); 12+ hours (succinate) | 6-7 hours |
| Metabolism | Liver (CYP2D6) | Kidneys (minimal metabolism) |
| Dosing Frequency | Twice daily (tartrate) or once daily (succinate) | Once or twice daily |
| Heart Failure Evidence | Strong (succinate form) | Weak/not recommended |
| Generic Cost | $4-$15/month | $4-$10/month |
Effectiveness for High Blood Pressure
Both medications effectively lower blood pressure, typically reducing systolic pressure by 10 to 15 mmHg. However, current guidelines from the American College of Cardiology no longer recommend beta blockers as first-line treatment for uncomplicated hypertension. ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics are preferred. Beta blockers are now recommended primarily when hypertension coexists with another condition they treat, such as heart failure, post-heart attack care, or certain arrhythmias.
A notable difference emerged from a large Swedish study (the MERIT-HF trial) that showed metoprolol succinate (extended-release) reduced mortality in heart failure patients by 34%. Atenolol lacks comparable heart failure evidence and is generally not recommended for this indication. This distinction is one of the most clinically important differences in the metoprolol vs atenolol comparison.
Effectiveness for Other Heart Conditions
Post-Heart Attack (Secondary Prevention)
Metoprolol has stronger evidence for post-heart attack use. Multiple large trials have demonstrated that metoprolol reduces the risk of repeat cardiac events and death after a myocardial infarction. The Mayo Clinic lists post-MI care as one of metoprolol’s primary indications. Atenolol was commonly used for this purpose in the past but has weaker trial data supporting mortality benefit.
Arrhythmias
Both medications effectively control heart rate in atrial fibrillation and other supraventricular tachycardias. They work by slowing conduction through the AV node. In clinical practice, metoprolol is more commonly used in acute settings (IV metoprolol tartrate) while either drug may be used for chronic rate control.
Angina
Both metoprolol and atenolol are effective for stable angina, reducing the frequency and severity of chest pain episodes by lowering the heart’s workload. For migraine prevention, metoprolol has more supporting data, though both are used off-label for this purpose.
Side Effect Comparison
The side effect profiles of these two beta blockers overlap significantly, but a few meaningful differences exist due to their chemical properties.
Central nervous system effects: Because metoprolol is lipophilic (fat-soluble), it crosses the blood-brain barrier more readily than the water-soluble atenolol. This means metoprolol is more likely to cause vivid dreams, sleep disturbances, depression, and fatigue. Patients who experience significant CNS side effects on metoprolol may do better switching to atenolol. For a comprehensive look at metoprolol’s side effects, see our guide to metoprolol side effects.
Common side effects shared by both: Fatigue and tiredness (the most frequent complaint), dizziness, cold hands and feet, slow heart rate (bradycardia), and gastrointestinal symptoms. Sexual dysfunction, including erectile dysfunction, occurs with both drugs at similar rates (approximately 5 to 10% of users).
Kidney considerations: Atenolol is primarily eliminated through the kidneys, so dose adjustments are necessary in patients with impaired kidney function. Metoprolol is processed by the liver, making it the preferred choice for patients with chronic kidney disease. Conversely, metoprolol should be used cautiously in patients with significant liver disease.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience a heart rate below 40 beats per minute with dizziness or fainting, severe difficulty breathing, chest pain that is new or worsening, or signs of an allergic reaction including swelling of the face, lips, or throat.
Drug Interactions
Metoprolol is metabolized by the CYP2D6 enzyme in the liver, making it susceptible to interactions with drugs that inhibit this enzyme. According to the National Institutes of Health, common CYP2D6 inhibitors like fluoxetine (Prozac), paroxetine (Paxil), and bupropion (Wellbutrin) can significantly increase metoprolol blood levels, potentially causing excessive heart rate slowing and blood pressure drops.
Atenolol’s renal elimination means it has fewer metabolic drug interactions. This can be an advantage for patients taking multiple medications. Both drugs interact with calcium channel blockers (particularly verapamil and diltiazem), clonidine, and other heart-rate-lowering medications. Neither should be combined with these drugs without careful medical supervision.
Frequently Asked Questions
Can I switch from atenolol to metoprolol?
Yes, switching between these beta blockers is common. A typical conversion is atenolol 50 mg daily to metoprolol succinate 50 to 100 mg daily, though your doctor will adjust based on your response. The switch usually does not require a gradual taper from one to the other, but it should always be done under medical supervision.
Which beta blocker is better for anxiety?
Neither metoprolol nor atenolol is FDA-approved for anxiety. Propranolol (a non-selective beta blocker) is more commonly used off-label for performance anxiety and situational anxiety. That said, atenolol may be preferable if a beta blocker is chosen for anxiety-related symptoms because it causes fewer CNS effects than metoprolol.
Do beta blockers cause weight gain?
Beta blockers can cause modest weight gain of 2 to 4 pounds, primarily in the first few months of treatment. This is thought to result from reduced metabolic rate and decreased physical activity tolerance. Newer beta blockers like carvedilol and nebivolol may cause less weight gain, though data is mixed.
Can I exercise while taking metoprolol or atenolol?
Yes, but both medications will limit your maximum heart rate, which can feel like a ceiling on exercise intensity. You may need to adjust how you gauge workout effort, using perceived exertion rather than heart rate targets. Most people can maintain regular exercise routines on beta blockers after an adjustment period of 1 to 2 weeks.
What to Do Next
The metoprolol vs atenolol decision depends largely on your specific condition. If you have heart failure, metoprolol succinate is the clear choice backed by strong mortality data. If you are sensitive to CNS side effects like vivid dreams or fatigue, atenolol may be more tolerable. For patients with kidney problems, metoprolol’s liver metabolism is advantageous, while atenolol’s fewer drug interactions benefit patients on multiple medications.
If you are currently taking either medication and experiencing bothersome side effects, bring up the possibility of switching at your next appointment. Do not stop or change your dose without medical guidance, as abruptly discontinuing beta blockers can cause dangerous rebound increases in heart rate and blood pressure. Both medications are affordable, effective, and well-established, so the choice between them is often about finding the best individual fit. For related reading, see our article on symptoms of heart failure.